DaVita (DVA)
(Delayed Data from NYSE)
$139.16 USD
+1.75 (1.27%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $139.08 -0.08 (-0.06%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Brokerage Reports
0 items in cart
DaVita Inc. [DVA]
Reports for Purchase
Showing records 281 - 289 ( 289 total )
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Managed care survey indicates shift in dialysis provider contracts
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Survey says: Providers evaluating ways to lower costs under bundling
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Pre-announces Third Quarter Indicates Refinance Imminent.
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
OIG Report Highlights Value of Annual Update, Purchasing Power of Large Chains
Provider: FELTL & COMPANY
Company: DaVita Inc.
Industry: Medical - Outpatient and Home Healthcare
Initiating Coverage with a Strong Buy - Bundling presents under appreciated opportunity.
Provider: FELTL & COMPANY
Analyst: HOERNEMANN J